Reaction
Klebsiella Test Positive reporting signals
As of the last recalculation, Klebsiella Test Positive appears in 644 FAERS reports alongside 37 co-occurring drug terms. The strongest observed disproportionality signal is DIMENHYDRINATE (PRR 43.4).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Dimenhydrinate | 14 | 43.4 | 43.4 |
| Vincristine Sulfate | 37 | 43.2 | 43.3 |
| Ampicillin | 10 | 39.6 | 39.7 |
| Ampicillin Sodium | 10 | 39.6 | 39.7 |
| Pegaspargase | 13 | 35.0 | 35.0 |
| Leucovorin Calcium | 18 | 31.3 | 31.3 |
| Magnesium Sulfate In Water For | 12 | 30.9 | 31.0 |
| Irinotecan Hydrochloride | 12 | 30.7 | 30.7 |
| Cytarabine | 52 | 30.3 | 30.4 |
| Magnesium Sulfate Heptahydrate | 12 | 30.3 | 30.3 |
| Magnesium Sulfate | 12 | 30.3 | 30.3 |
| Gentamicin | 12 | 30.2 | 30.2 |
| Cefepime | 11 | 25.2 | 25.2 |
| Gentamicin Sulfate | 12 | 25.0 | 25.0 |
| Dextrose | 10 | 24.9 | 24.9 |
| Dextrose Monohydrate | 10 | 24.5 | 24.6 |
| Anti-Thymocyte Globulin (Rabbit) | 6 | 24.3 | 24.3 |
| Baricitinib | 7 | 23.7 | 23.7 |
| Polatuzumab Vedotin | 7 | 23.4 | 23.4 |
| Cefepime Hydrochloride | 11 | 22.4 | 22.4 |
| Bendamustine Hydrochloride | 8 | 21.8 | 21.9 |
| Mercaptopurine | 11 | 20.8 | 20.9 |
| Atovaquone | 5 | 20.2 | 20.2 |
| Doxorubicin Hydrochloride | 19 | 19.3 | 19.4 |
| Brentuximab Vedotin | 6 | 19.1 | 19.1 |
| Busulfan | 9 | 18.7 | 18.7 |
| Ifosfamide | 12 | 18.4 | 18.4 |
| Panitumumab | 8 | 16.7 | 16.7 |
| Azacitidine For | 9 | 16.2 | 16.2 |
| Bendamustine Hcl | 7 | 14.7 | 14.7 |
| Gemcitabine | 16 | 13.4 | 13.4 |
| Axicabtagene Ciloleucel | 4 | 13.2 | 13.2 |
| Gemcitabine Hydrochloride | 20 | 12.5 | 12.5 |
| Azacitidine | 10 | 11.0 | 11.1 |
| Ravulizumab | 4 | 9.6 | 9.6 |
| Emicizumab | 3 | 7.9 | 7.9 |
| Pegfilgrastim | 18 | 6.0 | 6.0 |